May is National Cancer Research Month. At Frontiers in Oncology, we are dedicated to spotlighting the groundbreaking discoveries transforming the landscape of cancer research and the unwavering dedication of the scientific community. We want to highlight recent discoveries in the field and raise awareness about the significance of early diagnosis, multidisciplinary management, and the pivotal role of technological innovation in combating cancers. We also want to inspire collaboration among researchers, healthcare professionals, patients, and the public.Cancer research encompasses a wide array of disciplines and innovative approaches to understand the complexities of cancer biology, discover new therapeutic strategies, and improve diagnostic and prevention methods. By spotlighting the latest breakthroughs and clinical trials, National Cancer Research Month emphasizes the importance of continued investment in research to accelerate progress and deliver life-saving treatments. One of the foundational aspects of cancer research is the development of advanced diagnostic tools that enable the early detection of cancer, which is crucial for improving survival rates and treatment success. Innovations in diagnostic technology, such as refined imaging techniques, molecular profiling, and liquid biopsies, are leading the way in identifying cancer at its earliest and most treatable stages. These cutting-edge approaches empower clinicians to make timely, informed decisions and tailor treatments to individual patients, ultimately enhancing care outcomes. Equally important in the fight against cancer is prevention. Research in cancer prevention focuses on identifying risk factors, such as genetic predispositions, environmental exposures, and lifestyle choices, that contribute to cancer development. By understanding these factors, we can establish effective prevention strategies, raise public awareness, and implement educational programs encouraging healthy behaviors.This Research Topic aims to provide a platform to spotlight the latest advancements and collaborative efforts that fuel ongoing innovations to improve cancer research and, ultimately, improve patient outcomes and prognosis. We encourage community engagement in discussions and initiatives that foster a deeper understanding of cancer prevention and early detection.• Machine Learning in Cancer Imaging and Therapy• Adaptive Radiotherapy• Identification and characterization of protein conformation-based novel cancer biomarkers• Targeting drug resistance mechanisms to improve cancer therapies and treatment• Immunotherapy and the role of tumor microenvironment in the role of cancer progression• Epigenetic therapies in cancerWe welcome Original Research, Reviews, Systematic Reviews, Case Reports, and Mini-Reviews.Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases that are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of the scope for this section and will not be accepted as part of this Research Topic.
May is National Cancer Research Month. At Frontiers in Oncology, we are dedicated to spotlighting the groundbreaking discoveries transforming the landscape of cancer research and the unwavering dedication of the scientific community. We want to highlight recent discoveries in the field and raise awareness about the significance of early diagnosis, multidisciplinary management, and the pivotal role of technological innovation in combating cancers. We also want to inspire collaboration among researchers, healthcare professionals, patients, and the public.Cancer research encompasses a wide array of disciplines and innovative approaches to understand the complexities of cancer biology, discover new therapeutic strategies, and improve diagnostic and prevention methods. By spotlighting the latest breakthroughs and clinical trials, National Cancer Research Month emphasizes the importance of continued investment in research to accelerate progress and deliver life-saving treatments. One of the foundational aspects of cancer research is the development of advanced diagnostic tools that enable the early detection of cancer, which is crucial for improving survival rates and treatment success. Innovations in diagnostic technology, such as refined imaging techniques, molecular profiling, and liquid biopsies, are leading the way in identifying cancer at its earliest and most treatable stages. These cutting-edge approaches empower clinicians to make timely, informed decisions and tailor treatments to individual patients, ultimately enhancing care outcomes. Equally important in the fight against cancer is prevention. Research in cancer prevention focuses on identifying risk factors, such as genetic predispositions, environmental exposures, and lifestyle choices, that contribute to cancer development. By understanding these factors, we can establish effective prevention strategies, raise public awareness, and implement educational programs encouraging healthy behaviors.This Research Topic aims to provide a platform to spotlight the latest advancements and collaborative efforts that fuel ongoing innovations to improve cancer research and, ultimately, improve patient outcomes and prognosis. We encourage community engagement in discussions and initiatives that foster a deeper understanding of cancer prevention and early detection.• Machine Learning in Cancer Imaging and Therapy• Adaptive Radiotherapy• Identification and characterization of protein conformation-based novel cancer biomarkers• Targeting drug resistance mechanisms to improve cancer therapies and treatment• Immunotherapy and the role of tumor microenvironment in the role of cancer progression• Epigenetic therapies in cancerWe welcome Original Research, Reviews, Systematic Reviews, Case Reports, and Mini-Reviews.Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases that are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of the scope for this section and will not be accepted as part of this Research Topic.